Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Associate Professor Margret Leosdottir

Skane University Hospital, Malmo (Sweden)

5 More presentations in this session

Presentation thumbnail

LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study

Doctor A. Maggioni (Florence, IT)

Presentation thumbnail

Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London

Doctor M. Akhtar (London, GB)

Presentation thumbnail

Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients

Ms J. Schubert (Uppsala, SE)

Presentation thumbnail

A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study

Professor K. Ray (London, GB)

Presentation thumbnail

Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation

Professor F. Schiele (Besancon, FR)

Access the full session

Session thumbnail

Registries, observational, and other studies on lipids

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources